Managed team of clinical scientists, technicians, technologists, office staff, and schedules. Oversaw budget, facility maintenance, and equipment maintenance. Served as CLIA / CAP technical supervisor.-Led all lab operations and personnel, ensuring compliance with CLIA and CAP standards for client projects.-Provided technical expertise on sales calls with prospective customers, offering wet lab insights and sampling recommendations.-Spearheaded improvement initiatives across business units, elevating efficiency and inter-departmental collaboration.-Built and maintained strong vendor relationships, verifying reliable supply chains and robust business continuity programs.-Developed and tracked KPIs, identifying and optimizing high-cost processes to upgrade overall functional performance.-Introduced lean methodologies, achieving nearly $1.5M reduction in running costs and lessening nonconforming events 60% within 12 months.-Developed comprehensive in-house biosafety and chemical safety programs as onsite biosafety officer, guaranteeing safe environments and regulatory abidance.-Advised regulatory requirements for importation and transportation permits, facilitating seamless operations across regions.

Directed laboratory functions and lab construction. Advanced facility capabilities and safety practices and optimized workflows across high-containment BSL2 and BSL3 labs.-Designed and maintained critical safety protocols, fostering compliant and efficient environment.-Conducted non-select agent BSL3 work with infectious agents, such as SARS-CoV-2, Mycobacterium tuberculosis, rabies surveillance, maintaining strict biosafety standards.

Coordinated pandemic logistics, acquisition of testing supplies, vaccine storage and distribution, and clinical testing. Supported public health initiatives during COVID-19.-Assisted COVID-19 wastewater surveillance and SARS-CoV-2 variant tracking projects, providing crucial genomic data for public health response.

Navigated molecular diagnostic development and genomic epidemiology projects and contributed to accurate and timely disease detection.-Collaborated on grant applications and authored publications, promoting funding acquisition and refining infectious disease research.

Helped TGen North and TGen Institute biosafety committees and guided biosafety protocols and regulatory adherence.-Administered 1st southwest U.S. FDA GenomeTrakr site, optimizing national surveillance of foodborne pathogens.-Cooperated with health agencies on infectious disease investigations, leveraging genomic tools to uncover outbreak origins.

Responsible for on-site development, implementation, and oversight of protocols to establish an FDA next generation sequencing pipeline (GenomeTrakr), using Illumina sequencing technology, to identify foodborne outbreaks of Salmonella, E. coli, Campylobacter and Listeria.